Submitted by Anonymous (not verified) on 1 July 2026 - 13:20
Human medicines European public assessment report (EPAR): Teriflunomide Viatris (previously Teriflunomide Mylan), teriflunomide, Date of authorisation: 09/11/2022, Revision: 9, Status: Authorised
Source: